N. Pendleton et al., SIMPLE CYTOKERATINS IN THE SERUM OF PATIENTS WITH LUNG-CANCER - RELATIONSHIP TO CELL-DEATH, European journal of cancer, 30A(1), 1994, pp. 93-96
An important role in differentiation and proliferation has been demons
trated for the 20 cytokeratin (CK) polypeptides. The serum of 24 patie
nts with biopsy-proven non-small cell lung cancer (NSCLC) and a simila
r number of controls was examined for evidence of CK8 and CK18. Using
enzyme-linked immunosorbent assay (ELISA), all the control sera were n
egative, but 9 of the 24 patients were positive (mean 2.62 ng/ml; rang
e 1.4-5.8; P = 0.0036). Western blotting confirmed the results of the
ELISA in all cases, and indicated full size CK polypeptides. Advanced
stage disease patients were more likely to be seropositive (P = 0.0002
4). Biopsy specimens showed CK8 expression in all 24 cases by immunoch
emistry and CK18 in 22 cases. This is the first study to demonstrate t
hat a subgroup of NSCLC patients have intact CK8 and CK18 peptides in
their serum, and their detection may correlate with advanced disease.